← Leaderboards
Moorthy P. Ponnusamy
University Of Nebraska Medical Center
$2,721,536
Attributed
$5,078,638
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,078,638 · 3
By mechanism
R01$4,714,204 · 2
K22$364,434 · 1
Top collaborators
- Surinder Kumar Batra12 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Ravi Salgia$9,622,551
- Pi-Wan Cheng$3,131,854
- Maneesh Jain$6,905,007
- Ram I Mahato$10,713,899
- Jixin Dong$5,759,083
Others in their field
Top investigators on “Neoplasm Metastasis”
- Charles A Coltman · Southwest Oncology Group$110,022,912
- Timothy J Eberlein · Washington University$54,581,241
- Samuel A Wells · Duke University$31,864,469
- William George Nelson · Johns Hopkins University$31,104,956
- Zaver M Bhujwalla · Johns Hopkins University$30,433,864
- Leonidas C Platanias · University Of Illinois At Chicago$30,290,986
Research focus
Neoplasm MetastasisCancer Stem CellMalignant Neoplasm Of PancreasTumor ProgressionMouse ModelDisease ProgressionPlaySamplingStructureApplications GrantsCrispr/Cas TechnologyOrganoidsMutationAffectKnock-OutMolecularOncogenicTissuesBaseCessation Of LifeAntigensCd44 GeneMalignant NeoplasmsNovel Therapeutics
Grant awards (15)
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer$1,028,395
R01 · FY2025 · CA · contact PI
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer$114,096
R01 · FY2025 · CA · contact PI
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer$488,488
R01 · FY2024 · CA · contact PI
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer$52,806
R01 · FY2024 · CA · contact PI
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer$503,508
R01 · FY2023 · CA · contact PI
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer$526,941
R01 · FY2022 · CA · contact PI
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia$421,180
R01 · FY2021 · CA · contact PI
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia$421,180
R01 · FY2020 · CA · contact PI
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia$362,607
R01 · FY2019 · CA · contact PI
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia$47,357
R01 · FY2019 · CA · contact PI
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia$373,823
R01 · FY2018 · CA · contact PI
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia$373,823
R01 · FY2017 · CA · contact PI
PD2/Paf1 and pancreatic cancer stem cells$120,578
K22 · FY2016 · CA · contact PI
PD2/Paf1 and pancreatic cancer stem cells$120,578
K22 · FY2015 · CA · contact PI
PD2/Paf1 and pancreatic cancer stem cells$123,278
K22 · FY2014 · CA · contact PI